Literature DB >> 19213233

Successful treatment of disseminated granuloma annulare with adalimumab.

David Rosmarin1, Anne LaRaia, Scott Schlauder, Alice B Gottlieb.   

Abstract

A 61-year-old female with a 4-year history of disseminated granuloma annulare was successfully treated with the antitumor necrosis factor (TNF)-alpha antibody, adalimumab. The patient had failed high potency topical glucocorticoids, hydroxychloroquine, and narrow-band ultraviolet light (UV)-B phototherapy. Anti-TNF-alpha therapy may be a therapeutic option in patients with disseminated granuloma annulare poorly controlled with conventional medications.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19213233

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN： 1545-9616            Impact factor:   2.114


  5 in total

1.  Treatment of widespread granuloma annulare with adalimumab: a case report.

Authors:  Heidi Kozic; Guy F Webster
Journal:  J Clin Aesthet Dermatol       Date:  2011-11

2.  Granulomatous Cutaneous Drug Eruptions: A Systematic Review.

Authors:  Nidhi Shah; Monica Shah; Aaron M Drucker; Neil H Shear; Michael Ziv; Roni P Dodiuk-Gad
Journal:  Am J Clin Dermatol       Date:  2021-01       Impact factor: 7.403

3.  Granuloma Annulare in the Setting of Secukinumab.

Authors:  Matthew L Clark; Courtney A Tobin; Angela Sutton; Tricia Ann Missall
Journal:  Case Rep Dermatol Med       Date:  2018-04-01

4.  Generalized granuloma annulare treated with monthly rifampicin, ofloxacin, and minocycline combination therapy.

Authors:  Shilpa Garg; Sukriti Baveja
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

5.  The role of anti-tumour necrosis factor in wound healing: A case report of refractory ulcerated necrobiosis lipoidica treated with adalimumab and review of the literature.

Authors:  Vijay Kumari Sandhu; Afsaneh Alavi
Journal:  SAGE Open Med Case Rep       Date:  2019-10-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.